Ligand-based virtual screening to predict inhibitors against metastatic lymph node 64.

Chitrala KN, Yeguvapalli S. Ligand-based virtual screening to predict inhibitors against metastatic lymph node 64. J Recept Signal Transduct Res. 2014 Apr; 34(2):92-6.

View in: PubMed

subject areas

Carrier Proteins
Cholesterol
Drug Evaluation, Preclinical
High-Throughput Screening Assays
Humans
Ligands
Membrane Proteins
Models, Molecular
Pharmaceutical Preparations
Protein Structure, Tertiary

authors with profiles

Kumaraswamy Naidu Chitrala, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support